Key result
Targeted device reprogramming restores AV synchrony and improves heart failure symptoms in RNRVAS.
Why the study?
Repetitive non-reentrant ventriculoatrial synchrony is an under-recognized pacemaker-mediated rhythm that can cause atrioventricular dyssynchrony and heart failure symptoms.
Does targeted device reprogramming improve heart failure symptoms in a patient with repetitive non-reentrant ventriculoatrial synchrony?
Case Report (n=1)
Does targeted device reprogramming improve heart failure symptoms in a patient with repetitive non-reentrant ventriculoatrial synchrony?
Answers are grounded in this paper and cite their sources.
Careful ECG analysis can reveal repetitive non-reentrant ventriculoatrial synchrony and guide simple pacemaker reprogramming to restore AV synchrony and improve heart failure symptoms.
BACKGROUND: Repetitive non-reentrant ventriculoatrial synchrony (RNRVAS) is an under-recognized pacemaker-mediated rhythm that can cause atrioventricular (AV) dyssynchrony and heart failure symptoms. CASE SUMMARY: A 65-year-old man with advanced nonischemic cardiomyopathy and dual-chamber implantable cardioverter-defibrillator presented with worsening heart failure symptoms. A 12-lead electrocardiogram (ECG) demonstrated ventricular pacing with retrograde atrial conduction followed by atrial pacing with functional atrial noncapture, consistent with RNRVAS. Device interrogation confirmed frequent automatic mode switching episodes. Targeted device reprogramming, including lowering the lower rate limit and shortening the AV delay restored AV synchrony and resulted in clinical improvement. DISCUSSION: RNRVAS may evade standard device detection algorithms and present with subtle but clinically significant hemodynamic compromise. Careful ECG analysis can facilitate timely diagnosis and guide simple programming adjustments, with profound symptom improvement. TAKE-HOME MESSAGE: Careful analysis of surface ECGs can reveal RNRVAS and guide simple pacemaker reprogramming that restores AV synchrony and improves heart failure symptoms.
No takes yet. Share an insight, caveat, or question.
Vardar et al. (2026) conducted a case report in Repetitive non-reentrant ventriculoatrial synchrony (RNRVAS) and heart failure (n=1). Targeted device reprogramming was evaluated on Clinical improvement and restoration of AV synchrony. Targeted device reprogramming, including lowering the lower rate limit and shortening the AV delay, restored AV synchrony and improved heart failure symptoms in a patient with RNRVAS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: